...
机译:撤出腹膜透析后腹膜完整性的恢复:具有包膜性腹膜硬化风险的患者的特征
Division of Kidney and Hypertension Department of Internal Medicine Jikei University School of Medicine 3-25-8 Nishishinbashi Minato-ku Tokyo 105-8461 Japan;
Division of Kidney and Hypertension Department of Internal Medicine Jikei University School of Medicine 3-25-8 Nishishinbashi Minato-ku Tokyo 105-8461 Japan;
Division of Kidney and Hypertension Department of Internal Medicine Jikei University School of Medicine 3-25-8 Nishishinbashi Minato-ku Tokyo 105-8461 Japan;
Division of Kidney and Hypertension Department of Internal Medicine Jikei University School of Medicine 3-25-8 Nishishinbashi Minato-ku Tokyo 105-8461 Japan;
Division of Kidney and Hypertension Department of Internal Medicine Jikei University School of Medicine 3-25-8 Nishishinbashi Minato-ku Tokyo 105-8461 Japan;
Division of Kidney and Hypertension Department of Internal Medicine Jikei University School of Medicine 3-25-8 Nishishinbashi Minato-ku Tokyo 105-8461 Japan;
Division of Kidney and Hypertension Department of Internal Medicine Jikei University School of Medicine 3-25-8 Nishishinbashi Minato-ku Tokyo 105-8461 Japan;
Peritoneal dialysis (PD); Encapsulating peritoneal sclerosis (EPS); Risk factor; High-transport state; CA125; Post PD;
机译:撤消腹膜透析后恢复腹膜完整性:处于包囊性腹膜硬化风险中的患者的特征。
机译:仅使用生物相容性液体将腹膜硬化患者包封在腹膜透析患者中:Alport综合征是否是危险因素?
机译:仅使用生物相容性液体包裹腹膜透析患者的腹膜硬化:alport综合征是危险因素吗?
机译:一种封装腹膜硬化症的病例,涉及使用Icodextrin腹膜溶液
机译:腹膜透析和血液透析患者的生活质量:试点比较研究。
机译:基于基于基于矩阵金属蛋白酶-2的ROM图以评估在腹膜透析患者中包封腹膜硬化的风险
机译:腹膜透析尿囊灌洗后预防腹膜灌洗服用腹膜灌洗的队列研究